The development of effective vaccines and the discovery of antibiotics are the greatest public health successes in history. Despite these successes, infectious diseases remain the leading cause of morbidity and mortality worldwide. Fortunately, we are experiencing a resurgence in research focused on molecular microbiology and studies into host-pathogen interactions.
The Program in Microbial Pathogenesis within the Department of Pathology, Microbiology and Immunology was created to address the growing need for new therapeutics to treat infectious diseases. The Program brings together researches in both basic science and applied research to establish a community of investigators interested in discovery and therapeutic development. By combining Vanderbilt’s strengths in both basic and clinical science, we are poised to make numerous exciting discoveries in infection biology, and leverage these advances to develop new drugs to treat a variety of infectious diseases. For instance:
These are but a few of the Vanderbilt resources that are being employed by Program investigators to make important discoveries in the area of microbial pathogenesis. It is clearly an exciting time for infectious disease research.